Amplia Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Amplia Therapeutics Ltd. is scheduled to report earnings on May 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 14.61M	AU$ 1.85M	AU$ 1.11M	AU$ 1.24M	AU$ 2.23M
Total Assets	AU$ 24.48M	AU$ 10.88M	AU$ 9.12M	AU$ 9.19M	AU$ 2.64M
Total Debt	AU$ 2.10M	AU$ 0.00	AU$ 0.00	AU$ 10.61K	AU$ 0.00
Net Debt	AU$ -12.51M	AU$ -1.85M	AU$ -1.11M	AU$ -1.23M	AU$ -2.23M
Total Liabilities	AU$ 2.64M	AU$ 539.13K	AU$ 510.62K	AU$ 526.86K	AU$ 279.42K
Stockholders Equity	AU$ 21.85M	AU$ 10.34M	AU$ 8.61M	AU$ 8.66M	AU$ 2.36M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Amplia Therapeutics Ltd. Earnings and Revenue History

Income Statement >

Amplia Therapeutics Ltd. Debt to Assets

Balance Sheet >

Amplia Therapeutics Ltd. Cash Flow

Cash Flow >

Amplia Therapeutics Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing